Copyright
©2013 Baishideng Publishing Group Co.
World J Gastroenterol. Dec 21, 2013; 19(47): 9012-9019
Published online Dec 21, 2013. doi: 10.3748/wjg.v19.i47.9012
Published online Dec 21, 2013. doi: 10.3748/wjg.v19.i47.9012
Figure 2 Relative changes in the incidence of gastroenteropancreatic neuroendocrine tumor are depicted according to tumor site and sex.
A: Changes were calculated for the reference periods 1976-1978 and 2004-2006*; the intervals 1979-1981 and 2004-2006 were chosen for the stomach, since no gastric NE neoplasms were registered in women before 1979; B: Changes in incidence are presented as relative increments age-adjusted to the 1987 German standard population. The data shown originate from the former East German National Cancer Registry (DDR Krebsregister) for the years 1976-1978 or from its successor, the Joint Cancer Registry, for the time period 2004-2006. NE: Neuroendocrine.
- Citation: Scherübl H, Streller B, Stabenow R, Herbst H, Höpfner M, Schwertner C, Steinberg J, Eick J, Ring W, Tiwari K, Zappe SM. Clinically detected gastroenteropancreatic neuroendocrine tumors are on the rise: Epidemiological changes in Germany. World J Gastroenterol 2013; 19(47): 9012-9019
- URL: https://www.wjgnet.com/1007-9327/full/v19/i47/9012.htm
- DOI: https://dx.doi.org/10.3748/wjg.v19.i47.9012